14.3 months; HR 0.86; 95% CI, 0.72–1.02, p = 0.0407) did not reach statistical significance based on pre-specified p -value cutoffs.
← all excerpts
Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
1
—
—
14.3 months; HR 0.86; 95% CI, 0.72–1.02, p = 0.0407) did not reach statistical significance based on pre-specified p -value cutoffs.